A GLP-1 receptor agonist with an extended half-life achieved through albumin binding and DPP-4 resistance. FDA-approved forms exist for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Research-use materials are distinct from prescription formulations.
Code SOL saves 10% at Live Alpha Labs.